121 related articles for article (PubMed ID: 10601737)
1. Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens.
Sasaki T; Miosge N; Timpl R
Matrix Biol; 1999 Oct; 18(5):499-508. PubMed ID: 10601737
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV.
Mayer U; Aumailley M; Mann K; Timpl R; Engel J
Eur J Biochem; 1991 May; 198(1):141-50. PubMed ID: 2040276
[TBL] [Abstract][Full Text] [Related]
3. Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.
Giudici C; Raynal N; Wiedemann H; Cabral WA; Marini JC; Timpl R; Bächinger HP; Farndale RW; Sasaki T; Tenni R
J Biol Chem; 2008 Jul; 283(28):19551-60. PubMed ID: 18487610
[TBL] [Abstract][Full Text] [Related]
4. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens.
Sasaki T; Göhring W; Mann K; Maurer P; Hohenester E; Knäuper V; Murphy G; Timpl R
J Biol Chem; 1997 Apr; 272(14):9237-43. PubMed ID: 9083057
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV.
Maurer P; Hohenadl C; Hohenester E; Göhring W; Timpl R; Engel J
J Mol Biol; 1995 Oct; 253(2):347-57. PubMed ID: 7563094
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
Sasaki T; Hohenester E; Göhring W; Timpl R
EMBO J; 1998 Mar; 17(6):1625-34. PubMed ID: 9501084
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of the extracellular calcium-binding protein BM-40/secreted protein, acidic, rich in cysteine/osteonectin from the nematode Caenorhabditis elegans.
Maurer P; Sasaki T; Mann K; Göhring W; Schwarzbauer JE; Timpl R
Eur J Biochem; 1997 Aug; 248(1):209-16. PubMed ID: 9310380
[TBL] [Abstract][Full Text] [Related]
8. Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin).
Pottgiesser J; Maurer P; Mayer U; Nischt R; Mann K; Timpl R; Krieg T; Engel J
J Mol Biol; 1994 May; 238(4):563-74. PubMed ID: 8176746
[TBL] [Abstract][Full Text] [Related]
9. Recombinant and tissue-derived mouse BM-40 bind to several collagen types and have increased affinities after proteolytic activation.
Maurer P; Göhring W; Sasaki T; Mann K; Timpl R; Nischt R
Cell Mol Life Sci; 1997 May; 53(5):478-84. PubMed ID: 9176569
[TBL] [Abstract][Full Text] [Related]
10. High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin).
Maurer P; Mayer U; Bruch M; Jenö P; Mann K; Landwehr R; Engel J; Timpl R
Eur J Biochem; 1992 Apr; 205(1):233-40. PubMed ID: 1555584
[TBL] [Abstract][Full Text] [Related]
11. SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane.
Morrissey MA; Jayadev R; Miley GR; Blebea CA; Chi Q; Ihara S; Sherwood DR
PLoS Genet; 2016 Feb; 12(2):e1005905. PubMed ID: 26926673
[TBL] [Abstract][Full Text] [Related]
12. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.
Göhring W; Sasaki T; Heldin CH; Timpl R
Eur J Biochem; 1998 Jul; 255(1):60-6. PubMed ID: 9692901
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies.
Sweetwyne MT; Brekken RA; Workman G; Bradshaw AD; Carbon J; Siadak AW; Murri C; Sage EH
J Histochem Cytochem; 2004 Jun; 52(6):723-33. PubMed ID: 15150281
[TBL] [Abstract][Full Text] [Related]
14. A fragment of SPARC reflecting increased collagen affinity shows pathological relevance in lung cancer - implications of a new collagen chaperone function of SPARC.
Kehlet SN; Manon-Jensen T; Sun S; Brix S; Leeming DJ; Karsdal MA; Willumsen N
Cancer Biol Ther; 2018; 19(10):904-912. PubMed ID: 30067436
[TBL] [Abstract][Full Text] [Related]
15. Immunological screening of SPARC/Osteonectin in nonmineralized tissues.
Maillard C; Malaval L; Delmas PD
Bone; 1992; 13(3):257-64. PubMed ID: 1637573
[TBL] [Abstract][Full Text] [Related]
16. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
Lane TF; Sage EH
J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
[TBL] [Abstract][Full Text] [Related]
17. Identification of a sequence in the matricellular protein SPARC that interacts with the scavenger receptor stabilin-1.
Workman G; Sage EH
J Cell Biochem; 2011 Apr; 112(4):1003-8. PubMed ID: 21308731
[TBL] [Abstract][Full Text] [Related]
18. Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues.
Engel J; Taylor W; Paulsson M; Sage H; Hogan B
Biochemistry; 1987 Nov; 26(22):6958-65. PubMed ID: 3427055
[TBL] [Abstract][Full Text] [Related]
19. Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity.
Kaufmann B; Müller S; Hanisch FG; Hartmann U; Paulsson M; Maurer P; Zaucke F
Glycobiology; 2004 Jul; 14(7):609-19. PubMed ID: 15044389
[TBL] [Abstract][Full Text] [Related]
20. Immunoelectron microscopy of osteonectin and type I collagen in osteoblasts and bone matrix.
Romanowski R; Jundt G; Termine JD; von der Mark K; Schulz A
Calcif Tissue Int; 1990 Jun; 46(6):353-60. PubMed ID: 2364322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
